| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H19ClN2 |
| Molecular Weight | 274.788 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCN1CCC(=CC1)C2=CNC3=C2C=C(Cl)C=C3
InChI
InChIKey=ZRCUMOBNOPSLKM-UHFFFAOYSA-N
InChI=1S/C16H19ClN2/c1-2-7-19-8-5-12(6-9-19)15-11-18-16-4-3-13(17)10-14(15)16/h3-5,10-11,18H,2,6-9H2,1H3
| Molecular Formula | C16H19ClN2 |
| Molecular Weight | 274.788 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Tepirindole (also known as HR-592), an indole derivative has a high affinity for DA, 5-HT and NE receptors but has little properties to cause catalepsy. Animal experiments have shown that this compound could alleviate the adverse effect of neuroleptics such as haloperidol. Information about the current development of tepirindole is not available.
Approval Year
PubMed
|
|
SALT/SOLVATE -> PARENT |
Showing 1 to 1 of 1 entries
